Pan-Asia Tactical Market Calls (Quant-Driven), MRM Research

Nico Rosti

Senior Quantitative Strategist at Aethon Capital (crypto fund).

Quantitative Researcher, Algorithmic Trader and former Portfolio Manager at Capital Theory Investment Management, LLC (Austin, TX - USA). 

I specialize in systematic, short-term forecasting for US and Pan-Asian Stocks and Indexes. My methodology is centered on proprietary quantitative modeling (statistical study of trend persistence and mean reversion effects), leveraging probabilistic Bayesian models to predict tactical shifts over a 1-day to few-week horizon.

All models are explicitly human-built—no AI/machine learning—to eliminate black-box risk. This intensive, non-automated approach ensures that every Tactical Market Call is supported by a clear, explainable rationale.

Pan-Asia Tactical Market Calls (Quant-Driven)

A-Share Margin Trading Weekly (Jul 24th): PING AN INSURANCE, EAST MONEY INFORMATION, ZTE, MONTAGE

A-Share Margin Trading Weekly (Jul 17th): CHINA MINSHENG BANKING, PING AN INSURANCE, BOE, Moutai

A-Share Margin Trading Weekly (Jul 10th): GUOTAI HAITONG SECURITIES, ZTE, SMIC, CAMBRICON

MRM Research

Quantitative Research

Equity Derivatives

Eoptolink Technology   / Equity Derivatives

<ul>
<li>
<a href="https://www.smartkarma.com/entities/eoptolink-technology-inc-ltd" target="_blank" data-smartkarma-citation="entities:29558:1" rel="noopener">Eoptolink Technology (300502 CH)</a> submitted its HK IPO listing application to the Hong Kong Exchanges and Clearing (HKEX) in mid-July 2026. Deal size target: $5 billion USD.</li>
<li>Stock is down for five consecutive weeks. Q2 earnings report on August 25th is expected to significantly beat market consensus, driven by expanding global demand for high-speed AI interconnects.</li>
<li>Our model has identified an asymmetrical risk, buy opportunity ahead of the upcoming release of the Q2 earnings.</li>
</ul>



Eoptolink Technology (300502 CH) submitted its HK IPO listing application to the Hong Kong Exchanges and Clearing (HKEX) in mid-July 2026. Deal size target: $5 billion USD.
Stock is down for five consecutive weeks. Q2 earnings report on August 25th is expected to significantly beat market consensus, driven by expanding global demand for high-speed AI interconnects.
Our model has identified an asymmetrical risk, buy opportunity ahead of the upcoming release of the Q2 earnings.


Eoptolink (300502 CH): Tactical Re-Entry Ahead of Q2 Print and $5B HK IPO